|
Q4 2018
Filed on Feb 11, 2019
|
3,290
|
$49.08 - $72.33
$161K - $238K
|
|
|
Q4 2018
Filed on Feb 11, 2019
|
2,935
|
$50.8 - $69.24
$149K - $203K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,703
|
$14.49 - $17.8
$155K - $191K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
24,186
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
1,591
|
$107.2 - $130.44
$171K - $208K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
3,190
|
$52.78 - $65.41
$168K - $209K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
3,928
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
88,746
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,880
|
$0.91 - $4.15
$9.9K - $45.2K
|
|
Valeant Pharmaceuticals Intl
|
Q3 2018
Filed on Nov 09, 2018
|
20,944
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
13,229
|
$24.99 - $41.15
$331K - $544K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,632
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
2,723
|
$71.77 - $105.53
$195K - $287K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
19,517
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
32,097
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
6,000
|
$35.8 - $41.2
$215K - $247K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
11,100
|
$2.6 - $3.3
$28.9K - $36.6K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
3,886
|
$42.73 - $63.78
$166K - $248K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,042
|
$18.7 - $25.0
$188K - $251K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
3,407
|
$68.08 - $72.45
$232K - $247K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
12,796
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
11,405
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,999
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
8,625
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
1,461
|
$137.53 - $151.08
$201K - $221K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
5,765
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
23,209
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
12,448
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
1,231
|
$163.91 - $201.51
$202K - $248K
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
13,000
|
$6.01 - $6.49
$78.1K - $84.4K
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
7,934
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
21,269
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
24,304
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
21,260
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
22,433
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
3,669
|
N/A
|
|
Powershares Db Cmdty Idx Tra
|
Q2 2018
Filed on Aug 08, 2018
|
14,113
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
8,722
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
13,765
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
4,350
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
7,485
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
9,471
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
6,931
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
35,100
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
9,173
|
$22.04 - $23.63
$202K - $217K
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 08, 2018
|
6,416
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
11,778
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
16,520
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
16,125
|
N/A
|
|
|
Q2 2018
Filed on Aug 08, 2018
|
3,922
|
N/A
|
|